AGP Limited (PSX:AGP)

Revenue by Segment

Financials in millions PKR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Manufacture and Sale of Pharmaceutical Products		-	-	14.46B	9.32B	6.95B
Manufacture and Sale of Pharmaceutical Products Growth		-	-	55.19%	34.12%	11.08%
The Holding Company		18.54B	13.86B	-	-	-
The Holding Company Growth		33.82%	-	-	-	-
OBS AGP		6.26B	5.06B	-	-	-
OBS AGP Growth		23.73%	-	-	-	-
OBS PAK		3.24B	1.67B	-	-	-
OBS PAK Growth		93.46%	-	-	-	-
Elimination of Inter-Segment/Group Transactions		-3.00B	-1.84B	-	-	-
Total		25.03B	18.74B	14.46B	9.32B	6.95B
Total Growth		33.56%	29.63%	55.19%	34.12%	11.08%

Revenue by Geography

Financials in millions PKR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Pakistan		25.02B	19.34B	17.01B	9.41B	7.00B
Pakistan Growth		29.37%	13.71%	80.71%	34.51%	8.06%
Export		-	-	1.21B	558.92M	738.22M
Export Growth		-	-	117.26%	-24.29%	109.27%
Unallocated		-2.74B	-2.47B	-3.76B	-652.32M	-787.59M
Afghanistan		2.76B	1.87B	-	-	-
Afghanistan Growth		47.46%	-	-	-	-
Sri Lanka		2.19M	5.37M	-	-	-
Sri Lanka Growth		-59.31%	-	-	-	-
Total		25.03B	18.74B	14.46B	9.32B	6.95B
Total Growth		33.56%	29.63%	55.19%	34.12%	11.08%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 10, 2026

Data Sources Report a data error